New Delhi: Household paint samples taken from Delhi and Mumbai markets, are tested positive for presence of heavy metals’ high levels.

On Wednesday, a non-government organization “Toxics Link” released the study: “A Brush with Toxics: An Investigation on Lead in Household Paints in India.”

The study claims to have found high levels of lead in household paint samples. The samples were tested in as Indian laboratory as well as in New York Laboratory.

The UK Mobile Telecommunications and Health Research (MTHR) Programme’s report has revealed that mobile phones have no harmful effects on human health or biology.

According to the report, the majority of available evidences relate to short term use, and further research is needed before one can be certain of longer term effects.

London, Sept 14: A study has revealed that children of 15 months of age should have their cholesterol levels tested to prevent heart disease later in life.

Familial hypercholesterolaemia, meaning high cholesterol running in families, affects about two in every 1000 people and causes very high levels of low density lipoprotein (LDL) or ‘bad cholesterol’ in the blood. And high cholesterol carries a higher risk of death from coronary heart disease.

Washington, Sept 14: Eating an apple a day during pregnancy will not only kept the doctor away for expecting mums, but it can also help lower the risk of their kids developing asthma and wheezing.

The finding is based on a study published in the September issue of the journal Thorax in which researchers found that when women ate apples during pregnancy, their offspring tended to have a significantly lower risk of asthma and wheezing when they reached the age of five.

Washington, Sept 14: A new study of cervical cancer patients has revealed that irrespective of being big or small, if a tumour glows brightly in a PET (positron emission tomography) scan, it is likely to be more dangerous than dimmer tumours.

The study conducted by Washington University School of Medicine researchers reveals that PET ‘can reliably identify patients who have a poorer prognosis’.

New Delhi: Dr Reddy’s Laboratories (DRL) has received final approval for its Abbreviated New Drug Application (ANDA) for Ranitidine 150mg pill by the US Food and Drug Administration (FDA)

DRL is the only generic maker to get FDA authorization for this Abbreviated New Drug Application (ANDA) product accompanying the expiry of innovator's patents.

According to a statement, the company will distribute the 150 mg potency in blister counts of 8 and 24’s plus bottles of 50, 65 and 95 counts.